The purpose of this study is to asses the prognosis of STEMI patients without standard modifiable risk factors of cardiovascular disease (diabetes mellitus, hyperlipidemia, hypertension and cigarette smoking) compare to patients presenting at least one of these risk factors.
Study Type
OBSERVATIONAL
Enrollment
500
Institut du Coeur et des Vaisseaux Louis Mathieu
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
MACE (Major Adverse Cardiovascular Event)
Composite outcome including cardiovascular death or incidence of acute coronary syndrome, ischemic stroke or heart failure.
Time frame: 3 years
All-cause mortality
Time frame: 3 years
Number of patients presenting cardiovascular death during the follow-up
Number of patients presenting death due to fatal myocardial infarction, fatal ischemic stroke, sudden death, severe heart failure and cardiogenic shock during the follow-up.
Time frame: 3 years
Number of patients presenting heart failure during the follow-up
Number of patients hospitalized for acute heart failure during the follow-up, as well as patients presenting persistent symptoms of chronic heart failure after their STEMI (dyspnea NYHA \> 1) and/or long-terme need for diuretics.
Time frame: 3 years
Number of patients presenting ischemic stroke during the follow-up
Number of patients presenting fatal or non fatal ischemic stroke during the follow-up
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.